Загрузка...
Current status and perspectives in immunotherapy for metastatic melanoma
Metastatic melanoma was the first malignancy in which immune checkpoint inhibitors demonstrated their successful efficacy. Currently, the knowledge on the interaction between the immune system and malignant disease is steadily increasing and new drugs and therapeutic strategies are overlooking in th...
Сохранить в:
| Опубликовано в: : | Oncotarget |
|---|---|
| Главные авторы: | , , , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Impact Journals LLC
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5844761/ https://ncbi.nlm.nih.gov/pubmed/29552325 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.23746 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|